NewGen forms joint venture for UAE real estate development

Published 08/10/2025, 14:06
NewGen forms joint venture for UAE real estate development

BANGKOK - NewGenIvf Group Limited (NASDAQ:NIVF), a fertility services provider in Asia with annual revenue of $5.43 million and a market capitalization of $1.55 million, announced Wednesday it has established a joint venture with BNW Real Estate Development LLC to develop a plot of land in Ras Al Khaimah’s Beach District, UAE. According to InvestingPro analysis, the company currently maintains a weak financial health score of 1.39 out of 5.

NewGen will hold a 60% stake in the joint venture through its subsidiary, NewGenProperty Limited. According to the agreement, NewGenProperty will be responsible for funding 36% of the land purchase price, while BNW will cover all construction costs, management expenses, and a portion of marketing and brokerage fees. This comes as the company operates with a significant debt burden, with a debt-to-capital ratio of 0.74 and a concerning current ratio of 1.17.

The development project is estimated to be completed in 2028 and could generate net returns of up to $67 million for NewGenProperty, representing a 272% return on investment, according to a feasibility study prepared by BNW. The projection is based on a sale price of approximately $817 per square foot, with a total saleable area of 527,753 square feet.

"This partnership represents a pivotal moment for NewGenProperty as we seek to capture the exceptional growth opportunities in the UAE real estate market," said Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen.

BNW manages a real estate portfolio valued at approximately $6 billion and has launched six residential developments and two master-planned communities in the UAE.

The joint venture follows a Memorandum of Understanding signed between the two companies in July 2025 and marks a significant step in NewGen’s diversification strategy beyond its core fertility services business.

The information in this article is based on a company press release. With the stock down nearly 100% over the past year, investors seeking deeper insights into NIVF’s financial health and growth prospects can access additional analysis through InvestingPro, which offers 13 more exclusive ProTips and comprehensive financial metrics.

In other recent news, NewGenIvf Group Limited announced a significant valuation of its newly acquired cytometry intellectual property at $17.9 million, according to an independent report by a Big Four global accounting firm. This valuation has resulted in a bargain purchase gain of $19.2 million, boosting the company’s net asset value by approximately $8.9 per share. Additionally, NewGenIvf has expanded its presence in the U.S. fertility market by acquiring cytometry technology, which includes 18 fully-constructed cell-sorting systems, eight partially constructed units, and six patents related to advanced microfluidic systems. This acquisition builds on their earlier purchase of MicroSort technology, now branded as NewGenSort, which enhances in vitro fertilization procedures. Furthermore, NewGenIvf’s subsidiary, NewGenDigital, has entered into a partnership with BNW Real Estate Development LLC to develop a property in Ras Al Khaimah’s Beach District in the UAE. Under this joint venture, NewGenDigital will contribute 36% of the initial land cost, approximately $24 million, while BNW will cover the remaining 64%. These developments highlight NewGenIvf’s strategic moves in expanding its technological and geographical footprint.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.